AK
Andrew Kelly
Credentials: ·
History
- 2022–2024
Rheumatology
- 2019–2022
- 2015–2019
Medical School
Research
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer
Cancer Research · 2018 · 121 citations
The promise of epigenetic therapy: reprogramming the cancer epigenome
Review · Current Opinion in Genetics & Development · 2017 · First of 2 authors · 113 citations
Genome Medicine · 2013 · First of 16 authors · 90 citations
- DS
6 papers
- JI
5 papers
- JG
4 papers
3 papers
3 papers
2 papers
2 papers
2 papers
